151 related articles for article (PubMed ID: 8682619)
41. Epstein-Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving the NFkappaB pathway.
Vockerodt M; Tesch H; Kube D
Genes Immun; 2001 Dec; 2(8):433-41. PubMed ID: 11781710
[TBL] [Abstract][Full Text] [Related]
42. T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma lines.
Kiss C; Nishikawa J; Takada K; Trivedi P; Klein G; Szekely L
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4813-8. PubMed ID: 12672960
[TBL] [Abstract][Full Text] [Related]
43. Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays.
Bell AI; Groves K; Kelly GL; Croom-Carter D; Hui E; Chan ATC; Rickinson AB
J Gen Virol; 2006 Oct; 87(Pt 10):2885-2890. PubMed ID: 16963746
[TBL] [Abstract][Full Text] [Related]
44. How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?
Allday MJ
Semin Cancer Biol; 2009 Dec; 19(6):366-76. PubMed ID: 19635566
[TBL] [Abstract][Full Text] [Related]
45. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines.
Perez-Chacon G; de Los Rios C; Zapata JM
Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456
[TBL] [Abstract][Full Text] [Related]
46. EBV the prototypical human tumor virus--just how bad is it?
Thorley-Lawson DA
J Allergy Clin Immunol; 2005 Aug; 116(2):251-61; quiz 262. PubMed ID: 16083776
[TBL] [Abstract][Full Text] [Related]
47. [Epstein-Barr virus].
Tsurumi T
Nihon Rinsho; 2003 Mar; 61 Suppl 3():582-6. PubMed ID: 12718032
[No Abstract] [Full Text] [Related]
48. Reactivation of Epstein-Barr virus from latency.
Amon W; Farrell PJ
Rev Med Virol; 2005; 15(3):149-56. PubMed ID: 15546128
[TBL] [Abstract][Full Text] [Related]
49. Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis.
Tao Q; Swinnen LJ; Yang J; Srivastava G; Robertson KD; Ambinder RF
Am J Pathol; 1999 Aug; 155(2):619-25. PubMed ID: 10433954
[TBL] [Abstract][Full Text] [Related]
50. Spontaneous loss of viral episomes accompanying Epstein-Barr virus reactivation in a Burkitt's lymphoma cell line.
Srinivas SK; Sample JT; Sixbey JW
J Infect Dis; 1998 Jun; 177(6):1705-9. PubMed ID: 9607853
[TBL] [Abstract][Full Text] [Related]
51. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
Chabay P; De Matteo E; Merediz A; Preciado MV
Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
[TBL] [Abstract][Full Text] [Related]
52. Epstein-Barr virus integrates frequently into chromosome 4q, 2q, 1q and 7q of Burkitt's lymphoma cell line (Raji).
Gao J; Luo X; Tang K; Li X; Li G
J Virol Methods; 2006 Sep; 136(1-2):193-9. PubMed ID: 16806502
[TBL] [Abstract][Full Text] [Related]
53. Suberoylanilide hydroxamic acid induces viral lytic cycle in Epstein-Barr virus-positive epithelial malignancies and mediates enhanced cell death.
Hui KF; Chiang AK
Int J Cancer; 2010 May; 126(10):2479-89. PubMed ID: 19816947
[TBL] [Abstract][Full Text] [Related]
54. Epstein-Barr virus, the TCL-1 oncogene and Burkitt's lymphoma.
Bell A; Rickinson AB
Trends Microbiol; 2003 Nov; 11(11):495-7. PubMed ID: 14607063
[TBL] [Abstract][Full Text] [Related]
55. Efficient EBV superinfection of group I Burkitt's lymphoma cells distinguishes requirements for expression of the Cp viral promoter and can activate the EBV productive cycle.
Evans TJ; Jacquemin MG; Farrell PJ
Virology; 1995 Feb; 206(2):866-77. PubMed ID: 7856099
[TBL] [Abstract][Full Text] [Related]
56. The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.
Szenthe K; Koroknai A; Banati F; Bathori Z; Lozsa R; Burgyan J; Wolf H; Salamon D; Nagy K; Niller HH; Minarovits J
Biochem Biophys Res Commun; 2013 Apr; 433(4):489-95. PubMed ID: 23528241
[TBL] [Abstract][Full Text] [Related]
57. Epstein-Barr virus infection to Epstein-Barr virus-negative nasopharyngeal carcinoma cell line TW03 enhances its tumorigenicity.
Teramoto N; Maeda A; Kobayashi K; Hayashi K; Oka T; Takahashi K; Takada K; Klein G; Akagi T
Lab Invest; 2000 Mar; 80(3):303-12. PubMed ID: 10744066
[TBL] [Abstract][Full Text] [Related]
58. Proof for EBV's sustaining role in Burkitt's lymphomas.
Vereide D; Sugden B
Semin Cancer Biol; 2009 Dec; 19(6):389-93. PubMed ID: 19628040
[TBL] [Abstract][Full Text] [Related]
59. Epstein-Barr virus stimulates torque teno virus replication: a possible relationship to multiple sclerosis.
Borkosky SS; Whitley C; Kopp-Schneider A; zur Hausen H; de Villiers EM
PLoS One; 2012; 7(2):e32160. PubMed ID: 22384166
[TBL] [Abstract][Full Text] [Related]
60. Epstein-Barr virus promotes genomic instability in Burkitt's lymphoma.
Kamranvar SA; Gruhne B; Szeles A; Masucci MG
Oncogene; 2007 Aug; 26(35):5115-23. PubMed ID: 17325665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
